FNS  Vol.5 No.13 , July 2014
Antihypertensive Properties on Spontaneously Hypertensive Rats of Peptide Hydrolysates from Silkworm Pupae Protein
Abstract: Peptide hydrolysates of silkworm pupae protein with molecular weight of less than 5000 Da were prepared by ultrafiltration. The extracted peptide hydrolysates of silkworm pupae protein had inhibitory action on angiotensin-I-converting enzyme activity in vitro. The hydrolysates were orally administered to spontaneously hypertensive rats (SHR) in one period and long-term (four weeks). The results showed that the systolic blood pressure (SBP) of the treatment groups decreased in a dose-related manner. After one oral administration of silkworm protein hydrolysates with doses of 60, 20 and 5 mg/kg, the SBP of SHR decreased by 21.5, 13.8, and 9.0 mmHg in 1.5 h. After four weeks of the treatment in 80 mg/kg, the SBP decreased by 25 mmHg, with the antihypertensive activity close to 4 mg/kg of captopril; the SBP of the 40 mg/kg dose group also decreased by 17.5 mmHg. The peptide hydrolysate did not affect the SBP in normal, non-hypertensive rats in one period and long-term treatments. The acute toxicity research showed that the peptide hydrolysates were safe and without side effects. This research would be helpful in exploring the silkworm protein peptides as functional components for the antihypertension treatment.
Cite this paper: Wang, W. , Wang, N. and Zhang, Y. (2014) Antihypertensive Properties on Spontaneously Hypertensive Rats of Peptide Hydrolysates from Silkworm Pupae Protein. Food and Nutrition Sciences, 5, 1202-1211. doi: 10.4236/fns.2014.513131.

[1]   Lee, H.J. (1995) Biopharmaceutical Properties and Pharmacokineties of Peptide and Protein Drugs. In: Talor, M.D. and Amidon, G.L., Eds., Peptide-Based Drugs Design, ACS Professional Reference Book, American Chemical Society, Washington DC, 69.

[2]   Fei, Y.J., Yoshikatsu, K., Stephan, N., Vadivel, G., Frederick, H.L., Michael, F.R., Satish, K.S., Walter, F.B. and Matthias, A.H. (1994) Expression Cloning of a Marnmaliam Proton-Coupled Oligopeptide Transporter. Nature, 368, 563-566.

[3]   Dzau, V.J., Sasamura, H. and Hein, L. (1993) Heterogeneity of Angiotensin Synthetic Pathways and Receptor Subtypes: Physiological and Pharmacological Implications. Journal of Hypertension. Supplement, 11, 13-18.

[4]   Kim, S. and Iwao, H. (2000) Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases. Pharmacological Reviews, 52, 11-34.

[5]   Roks, A., Buikema, H., Pinto, Y.M. and Van Gilst, W.H. (1997) The Renin-Angiotensin System and Vascular Function. The Role of Angiotensin II, Angiotensin-Converting Enzyme, and Alternative Conversion of Angiotensin I. Heart and Vessels, 12, 119-124.

[6]   Zimmerman, B.G. and Dunham, E.W. (1997) Tissue Renin-Angiotensin System: A Site of Drug Action. Annual Review of Pharmacology and Toxicology, 37, 53-69.

[7]   Ehlers, M.R., Fox, E.A., Strydom, D.J. and Riordan, J.F. (1989) Molecular Cloning of Human Testicular Angiotensin-Converting Enzyme: The Testis Isozyme Is Identical to the C-Terminal Half of Endothelial Angiotensin-Converting Enzyme. Proceedings of the National Academy of Sciences of the United States of America, 86, 7741-7745.

[8]   Marta, M., Rosina, L.F., Mercedes, R. and Amaya, A. (2005) Short-Term Effect of Egg-White Hydrolysate Products on the Arterial Blood Pressure of Hypertensive Rats. British Journal of Nutrition, 5, 731-737.

[9]   Muguerza, B., Ramos, M., Sánchez, E., Manso, M.A., Miguel, M., Aleixander, A., Delgado, M.A. and Recio, I. (2006) Antihypertensive Activity of Milk Fermented by Enterococcus faecalis Strains Isolated from Raw Milk. International Dairy Journal, 16, 61-69.

[10]   Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S. and Takano, T. (1995) Purification and Characterization of Angiotensin-I-Converting Enzyme Inhibitors from sour Milk. Journal of Dairy Science, 78, 777-783.

[11]   Wang, W., Shen, S.R., Chen, Q.H., Ruan, H., He, G.Q. and Undurti, N.D. (2008) Hydrolysates of Silkworm Pupae (Bombyx mori) Protein Is a New Source of Angiotensin-I-Converting Enzyme Inhibitory Peptides (ACEIP). Current Pharmaceutical Biotechnology, 9, 307-314.

[12]   Wang, W., Wang, N., Zhang, Y., Cai, Z., Chen, Q.H. and He, G.Q. (2013) A Convenient RP-HPLC Method for Assay Bioactivities of Angiotensin I-Converting Enzyme Inhibitory Peptides. ISRN Biotechnology, 2013, Article ID: 453910.

[13]   Wang, W., Wang, N., Zhou, Y., Zhang, Y., Xu, L.H. and Xu, J.F. (2010) Isolation of a Novel Peptide from Silkworm Pupae Protein Components and Interaction Characteristics to Angiotensin I-Converting Enzyme. European Food Research and Technology, 232, 29-38.

[14]   Buñag, R.D. (1973) Validation in Awake Rats of a Tail-Cuff Method for Measuring Systolic Pressure. Journal of Applied Physiology, 34, 279-282.

[15]   Rone, G., Chappel, C.I. and Balazs, T. (1995) An Infarct-Like Myocardial Lesion and Other Toxic Manifestation Produced by Isoproterenal in the Rat. Archives of Pathology Laboratory Medicine, 67, 443-455.

[16]   Michio, M., Abdulatef, M.A., Kazunori, K., Satoshi, K., Masugi, M. and Toyoo, N. (2009) Identification of Pro-Drug Type ACE Inhibitory Peptide Sourced from Porcine Myosin B: Evaluation of Its Antihypertensive Effects in Vivo. Food Chemistry, 114, 516-522.

[17]   Ukeda, H., Matsuda, H., Osajima, K., Matsufuji, H., Matsui, T. and Osajima, Y. (1992) Peptides from Peptic Hydrolysate of Heated Sardine Meat That Inhibit Angiotensin I Converting Enzyme. Nippon Nōgeikagaku Kaishi, 66, 25-29.

[18]   Fujita, H., Yokoyama, K. and Yoshikawa, M. (2000) Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins. Journal of Food Science, 65, 564-569.

[19]   Je, J.Y., Park, J.Y., Jung, W.K., Park, P.J. and Kim, S.K. (2005) Isolation of Angiotensin I Converting Enzyme (ACE) Inhibitor from Fermented Oyster Sauce, Crassostrea gigas. Food Chemistry, 90, 809-814.

[20]   Hiroyuki, F., Tomohide, Y. and Kazunori, O. (2001) Effects of an Ace-Inhibitory Agent, Katsuobushi Oligopeptide, in the Spontaneously Hypertensive Rat and in Borderline and Mildly Hypertensive Subjects. Nutrition Research, 21, 1149-1158.

[21]   Hiroshi, Y., Norihide, T., Riichiro, O., Osamu, S., Hidemaro, T. and Toru, I. (2001) Antihypertensive Effect of ACE Inhibitory Oligopeptides from Chicken Egg Yolks. Comparative Biochemistry and Physiology Part C, 128, 27-33.

[22]   Wang, J.P., Hu, J.E., Cui, J.Z., Bai, X.F., Dua, Y.G., Miyaguchi, Y.J. and Lin, B.C. (2008) Purification and Identification of a ACE Inhibitory Peptide from Oyster Proteins Hydrolysate and the Antihypertensive Effect of Hydrolysate in Spontaneously Hypertensive Rats. Food Chemistry, 111, 302-308.

[23]   Li, G.H., Le, G.W., Shi, Y.H. and Shrestha, S. (2004) Angotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins and Their Physiological and Pharmacological Effects. Nutrition Research, 24, 469-486.

[24]   Fitzgerald, R.J., Murray, B.A. and Walsh, G.J. (2004) Hypotensive Peptides from Milk Proteins. Journal of Nutrition, 134, 980-988.

[25]   Miguel, M., Alonso, M.J., Salaices, M., Aleixandre, A. and López-Fandiño, R. (2007) Antihypertensive, ACE-Inhibitory and Vasodilator Properties of an Egg White Hydrolysate: Effect of a Simulated Intestinal Digestion. Food Chemistry, 104, 163-168.

[26]   Miguel, M., Contreras, M.M., Recio, I. and Aleixandre, A. (2009) ACE-Inhibitory and Antihypertensive Properties of a Bovine Casein Hydrolysate. Food Chemistry, 112, 211-214.

[27]   Erdmann, K., Cheung, B.W.Y. and Schröder, H. (2008) The Possible Roles of Food-Derived Bioactive Peptides in Reducing the Risk of Cardiovascular Disease. The Journal of Nutritional Biochemistry, 19, 643-654.

[28]   Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, M. and Osajima, Y. (1994) Angiotensin I-Converting Enzyme Inhibitory Peptides in an Alkaline Protease Hydrolyzate Derived from Sardine Muscle. Bioscience, Biotechnology, and Biochemistry, 58, 2244-2245.

[29]   Vermeirssen, V., Van Camp, J. and Verstraete, W. (2004) Bioavailability of Angiotensin I Converting Enzyme Inhibitory Peptides. British Journal of Nutrition, 92, 357-366.

[30]   Gardner, M.L. (1988) Gastrointestinal Absorption of Intact Proteins. Annual Review of Nutrition, 8, 329-350.

[31]   Webb, K.E. (1990) Intestinal Absorption of Protein Hydrolysis Products: A Review. Journal of Animal Science, 68, 3011-3022.

[32]   Masuda, O., Nakamura, Y. and Takano, T. (1996) Antihypertensive Peptides Are Present in Aorta after Oral Administration of Sour Milk Containing These Peptides to Spontaneously Hypertensive Rats. Journal of Nutrition, 126, 3063-3068.

[33]   Roberts, P.R., Burney, J.D., Black, K.W. and Zaloga, G.P. (1999) Effect of Chain Length on Absorption of Biologically Active Peptides from the Gastrointestinal Tract. Digestion, 60, 332-337.